REQUEST A DEMO
Total
USD $0.00
Search more companies

Hameln Rds S. R. O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hameln Rds S. R. O. Profile Updated: November 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hameln Rds S. R. O. is a company based in Slovakia, with its head office in Modra. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on June 15, 1995. Hameln Rds S. R. O. currently employs 100 - 149 (2023) people. From the latest financial highlights, Hameln Rds S. R. O. reported a net sales revenue drop of 8.85% in 2023. A growth of 14.95% was recorded in its total assets. In 2023, Hameln Rds S. R. O.’s net profit margin decreased by 5.04%.

Headquarters
Horna, 36
Modra; Bratislavsky; Postal Code: 90001

Contact Details: Purchase the Hameln Rds S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Hameln Rds S. R. O. report to view the information.
Outstanding Shares:
Purchase the Hameln Rds S. R. O. report to view the information.
Registered Capital:
Purchase the Hameln Rds S. R. O. report to view the information.
Incorporation Date:
June 15, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hameln Rds S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.85%
Total operating revenue
-8.7%
Operating profit (EBIT)
-59.85%
EBITDA
-41.98%
Net Profit (Loss) for the Period
-63.54%
Total assets
14.95%
Total equity
7.68%
Operating Profit Margin (ROS)
-6.05%
Net Profit Margin
-5.04%
Return on Equity (ROE)
-14.05%
Debt to Equity Ratio
0.05%
Quick Ratio
0.11%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?